EOS imaging Receives CE Mark for spineEOS Online 3D Surgical Planning App
EOS imaging received CE Mark approval for spineEOS, online 3DÂ planning software based on bi-planar imaging. Feb 29, 2016
Spine Wave Licenses Patents from Atlas Spine
Spine Wave licensed True Position® Pivoting Interbody Spacer IP from Atlas Spine. Feb 29, 2016
Cardinal Spine Receives FDA 510(k) Clearance for Cervical Vertebral Body Replacement
Cardinal Spine received FDA 510(k) clearance for the C-VBR cervical vertebral body replacement, reportedly the 2nd cervical VBR to be cleared by FDA and the 1st such device designed with no possibility of reduction in height after surgery. Feb 29, 2016
Extremity Medical Commences U.S. Launch of IO FIX 2.0
Extremity Medical commenced U.S. launch of IO FIX 2.0™ implants and instruments for midfoot fusion indications. Feb 29, 2016
Bone Biologics Completes $5.75 Million Funding Round
Bone Biologics completed a US $5.75MM funding round to support development of a bone graft substitute for initial focus on spinal fusion. Feb 29, 2016
Episurf Granted U.S. Patent
Episurf Medical was granted a U.S. patent covering a method to manufacture patient-specific joint implants and associated surgical tools. Feb 25, 2016
Study of PEMF in Disc Degeneration
Study results suggest that use of pulsed electromagnetic field therapy, such as Orthofix’s Physio-Stim®, may reduce cellular inflammation and degredation in intervertebral disc cells. Feb 25, 2016
Fidia to Introduce Hymovis, Next-Generation Hyaluronan
Fidia will commence U.S. launch of Hymovis® 2-injection highly viscoelastic hyaluronan, indicated to treat knee OA pain. Feb 25, 2016
Study Results: ReLeaf Catheter Supports Cost-effective Post-op Pain Management
Preliminary study results indicate that the Vital 5 ReLeaf Catheter improved pain scores and reduced post-op narcotic use following orthopaedic and spinal surgeries, and may support a transition to outpatient procedures. Feb 24, 2016
Study Results Demonstrate Statistically Significant Reduction of Bacteria With BioTy
Study findings demonstrate a statistically significant reduction in bacteria on implant surfaces processed with Tyber Medical’s BioTy™ Modified Surface Treatment. Feb 24, 2016
